ORA Research News - Monday, March 29, 2021
OCAST’s Oklahoma Applied Research Support (OARS) program specifications have changed. Please refer to the attached document.
Metabolomics Resource at OUHSC
The survey link is: https://ouhsc.qualtrics.com/jfe/form/SV_82FtfmR44aXU9tI
Jolyn Fernandes, MS, Ph.D., was recently recruited to OUHSC as Assistant Professor of Pediatrics, and the Associate Director of Metabolomics at Laboratory for Molecular Biology and Cytometry Research. Dr. Fernandes is building high-resolution high-throughput Metabolomics infrastructure at OUHSC campus. Metabolomics platforms are yielding important new insights into normal physiological processes, in pathology of disease and in treatment outcomes across multidisciplinary fields of basic science and clinical translation including Pediatrics, Diabetes, Cancer, Obesity, Immunology, Aging and Environmental Science. Metabolites such as sugars, amino acids, lipids etc have varied and important roles as signaling molecules, energy intermediates, microbiome derived metabolites, immune regulators, nutrient and environmental sensors. Dr. Fernandes has developed a short survey to capture the need for Metabolomics platforms at OUHSC from previous users who may have outsourced these capabilities and to inform new users of available resources in the near future. Please take a few minutes to address this quick one page survey to help identify metabolomics user interests across OU.
OUHSC HSC COVID-19 Return Plan - now the HSC COVID-19 Response Plan - effective February 16, 2021.
This revised Plan (https://www.ouhsc.edu/coronavirus) includes some minor clarifications to current HSC COVID-19 protocols, as well as some more substantive revisions, including: Adoption and implementation of updated testing and quarantine/isolation protocols following employee and student return from international travel and from cruises, based on recent federal executive order requirements (Sections VIII, IX). Please note that under the new protocols, individuals returning from international travel or from domestic or international cruises will typically have to quarantine/isolate from campus for 7 calendar days and receive a negative test prior to return. Individuals traveling internationally or taking cruises must be prepared to take leave (paid or unpaid, as appropriate) during the quarantine/isolation period communicated by Student/Employee Health, particularly if their position or responsibilities are not approved for or appropriate for remote work. Students must be prepared to be away from academic and clinical responsibilities during the designated quarantine/isolation period. Requirement that even those fully vaccinated must complete the online COVID-19 Screening and Reporting Tool (Sections VII, IX). At this time, the CDC has issued limited guidance on how completion of the COVID-19 vaccine series will impact exposure assessment. We will continue to monitor and will make adjustments to this requirement as needed. The Travel FAQs and the instructions for when to complete the online COVID-19 Screening and Reporting Tool, have been updated. The Tool itself has already been updated to reflect the changes above.
Gathering Market Insight for Innovation and Commercial Development
Help us showcase Oklahoma bioscience. You’re invited to attend an exclusive (and free!) lunch to learn more about OU research and how it can be used to enhance innovation. Dr. Meredith Wilkerson and Dr. Gina McMillen will showcase how OTC promotes your research and expertise to leaders in the biotech and pharma industries. Leveraging industry feedback to de-risk your technology and avoid barriers to market entry will also be discussed. Wednesday, March 31, 2021, 12 – 1 p.m. (CST) Online via ZOOM, To RSVP go to: https://oklahoma.zoom.us/meeting/register/tJUldequqzsrHdLjeDsjZm2U9V00_WlSgCK_
ORA Noon Conference offered via Zoom March 30, 2021 at 1:00 pm Topic: Writing the NIH Biosketch - The NIH biosketch provides an opportunity for each key person listed in an application to explain why they are well suited for their role in the project. This talk will address writing a compelling personal statement, touch on research products that may be included in the citations, discuss how to address factors that may have affected past productivity (for example, illness or family emergency), provide guidance on the contributions to science section, and present the guidelines for format and structure. *Important Update: A discussion of the upcoming changes to the NIH biosketch announced on 03/12/2021 and that will take effect on May 25, 2021 will also be included.
Please register in advance for this meeting: https://zoom.us/meeting/register/tJ0qcuGqqzMpGNIgHdLqWJZzYQVJHG17Iu5u After registering, you will receive a confirmation email containing information about joining the meeting.
COLLEGE OF MEDICINE ALUMNI ASSOCIATION: CALL FOR PROPOSALS
The College of Medicine Alumni Association is pleased to announces a call for proposals for COMAA Research Grants. The College of Medicine Research Fund was created with the proceeds from the first Evening of Excellence Alumni Research Dinner over 30 years ago. To date over $3.3 Million has been awarded. Successful applicants will be designated “College of Medicine Alumni Research Scholars.” Applications will be reviewed by a scientific panel whose composition will be determined on the types of applications received. Awards generally fall within the $20,000 to $45,000 range ($45,000 maximum request). Applications should be sent electronically to the mailbox: COMAA-Research@ouhsc.edu by 5 pm on Thursday, April 1, 2021. All applications must be routed through the Office of Research Administration and include the NIH face page (https://grants.nih.gov/grants/funding/phs398/fp1.pdf) signed by the appropriate ORA institutional official. If you should have any questions, please email Mary Beth Humphrey, MD, PhD, Associate Dean of Research College of Medicine, at email@example.com.
Office of Technology Commercialization presents four opportunities to engage with industry (click here for more information, or email firstname.lastname@example.org or email@example.com). Successful applicants will receive $15K for project costs. Preference will be given to those with access to assays that utilize human-derived cells or equivalent and are applicable for drug discovery. Proposal template available upon request (submission deadline 4/2/21). Takeda Pharmaceutical Company is seeking academic expertise for testing Takeda’s proprietary compounds in academic phenotypic cellular assays relating to:
- Gastroenterology: assays which represent GI motility or liver fibrosis disorders.
- Neuroscience: assays which represent neuromuscular and neurodegenerative disorders.
- Oncology: assays which represent cancer treatment using the anti-tumor immune response.
- Rare disease: assays which represent rare metabolic and hematology disorders.
Upcoming Changes to the Biographical Sketch and Other Support Format Page for Due Dates on or after May 25, 2021 (NOT-OD-21-073)
PRESBYTERIAN HEALTH FOUNDATION GRANTS – REQUEST FOR APPLICATIONS
The Presbyterian Health Foundation (PHF) will fund $4.15M in grants for 2021. Information on the PHF Grant Programs for Spring 2021 and Guidelines and Application for each of the grant programs listed below may be found at https://research.ouhsc.edu/Resources/PHF-Funding-2021. All guidelines have been recently updated to reflect that funds may not be requested for student tuition and fees. If you have any questions, please email ORA4PHF@ouhsc.edu.
New Investigator Seed (Requires nomination by College)
April 2, 2021
April 2, 2021
Clinician Scientist Development
April 9, 2021
April 9, 2021
April 30, 2021
REMINDER ON COVID-19 MITIGATION STRATEGIES IN THE RESEARCH ENVIRONMENT
With the current increase in COVID-19 cases across Oklahoma, this is a good time to do the following:
Oklahoma Covid-19 Working Group
Information on research activities in Oklahoma that address the Covid-19 pandemic has been added to the OCTSI Website (http://octsi.ouhsc.edu/covid-19%20working%20group) A list of investigators in the working group and their planned or ongoing projects are described. A list of funded Covid-19 Seed Projects at OUHSC and OU Norman is also included. To be added to the Oklahoma Covid-19 Working Group or to have your information updated, please contact: Mark L. Lang PhD, Presbyterian Health Foundation Presidential Professor, Department of Microbiology and Immunology, OUHSC (firstname.lastname@example.org ).
Up to date information on allowable OUHSC research activity in response to COVID-19 can be found at:
Announcement of Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows (NOT-OD-21-074) https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-074.html
Notice of NIH Participation in the National Robotics Initiative (NRI) (NOT-EB-21-008) https://grants.nih.gov/grants/guide/notice-files/NOT-EB-21-008.html
Notice of Informational Webinar on the NIGMS U-RISE and MARC Programs (NOT-GM-21-034) https://grants.nih.gov/grants/guide/notice-files/NOT-GM-21-034.html
Notice of Pre-Application Webinar and Frequently Asked Questions (FAQs) for NHLBI ENRICH RFA-HL-22-007 "Clinical Centers (UG3/UH3)" and RFA-HL-22-008 "Resource and Coordinating Center (U24)" (NOT-HL-21-004) https://grants.nih.gov/grants/guide/notice-files/NOT-HL-21-004.html
Notice of Information: NHLBI Extensions for Career Development Award (K01, K08, K23, K25) Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19 (NOT-HL-21-005) https://grants.nih.gov/grants/guide/notice-files/NOT-HL-21-005.html
Notice of Correction to NOT-OD-21-065 "Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Required)" for Clinical Trial Requirements (NOT-OD-21-072) https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-072.html
Notice of Information: NCATS to Issue an Emergency Competitive Revision Sole Source Award in Support of ACTIV-6 (NOT-TR-21-024) https://grants.nih.gov/grants/guide/notice-files/NOT-TR-21-024.html
Request for Information (RFI): Ovarian Anatomy Nomenclature Workshop Proposal at NICHD (NOT-HD-21-015) https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-015.html
Notice of Change to Key Dates for NIDA RFA-DA-22-004, " Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)" (NOT-DA-21-036) https://grants.nih.gov/grants/guide/notice-files/NOT-DA-21-036.html
Notice of Correction to R&R Budget Form for PAR-21-160, NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) (NOT-DE-21-002) https://grants.nih.gov/grants/guide/notice-files/NOT-DE-21-002.html
Notice of NICHD Participation in PA-20-183, "Research Project Grant (Parent R01 Clinical Trial Required)" (NOT-HD-21-019) https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-019.html
Notice of NICHD Participation on PA-20-184 "Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)" (NOT-HD-21-020) https://grants.nih.gov/grants/guide/notice-files/NOT-HD-21-020.html
Notice of Change to Key Dates of RFA-MH-21-120, "Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional)" (NOT-MH-21-220) https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-220.html
Notice of Change: Extension of PA-18-705 "SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)" (NOT-NS-21-042) https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-042.html
Notice of Correction for PAR-21-057 "Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)" (NOT-NS-21-043) https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-043.html
Notice of Correction for PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)" (NOT-NS-21-044) https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-044.html
Notice of Correction to Application and Submission Information for NOSI: Availability of Administrative Supplements for Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows (NOT-OD-21-070) (NOT-OD-21-075) https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-075.html
Notice of Change to NOT-OD-20-024: Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (NOT-OD-21-076) https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-076.html
Notice of Change to NOT-OD-20-025: Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project (NOT-OD-21-077) https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-077.html
Notice of Intent to Publish a Funding Opportunity Announcement for the ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial Not Allowed) (NOT-HL-21-002) https://grants.nih.gov/grants/guide/notice-files/NOT-HL-21-002.html
Notice of Intent to Publish a Funding Opportunity Announcement for the ARDS, Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01) (NOT-HL-21-006) https://grants.nih.gov/grants/guide/notice-files/NOT-HL-21-006.html
Notice of Intent to Publish a Funding Opportunity Announcement for Neurosurgeon Research Career Development Program (NRCDP) (K12) (NOT-NS-21-029) https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-029.html
Notice of Special Interest (NOSI): Fundamental Science Research on Complementary and Integrative Health Approaches (NOT-AT-21-006) https://grants.nih.gov/grants/guide/notice-files/NOT-AT-21-006.html
Notice of Special Interest (NOSI): Administrative Supplement for Genome-wide Genotyping of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data (NOT-CA-21-041) https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-041.html
Notice of Special Interest (NOSI): Conferences and Scientific Meetings Aimed at Supporting the National Eye Institutes Audacious Goals Initiative (NOT-EY-21-009) https://grants.nih.gov/grants/guide/notice-files/NOT-EY-21-009.html
Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed) (NOT-HL-21-007) https://grants.nih.gov/grants/guide/notice-files/NOT-HL-21-007.html
Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations (NOT-NS-21-037) https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-037.html
Notice of Special Interest (NOSI): Hyperacute MRI Imaging Studies to Understand How Brain Changes Affect AD/ADRD-Relevant Trajectories and Outcomes Post-Stroke (NOT-NS-21-038) https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-038.html
Notice of Special Interest (NOSI): Administrative Supplements for Collaborative Activities to Promote Sleep/Circadian Research in ADRD (NOT-NS-21-040) https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-040.html
Notice of Special Interest (NOSI) to add harassment as an area of interest to Research to Understand and Inform Interventions that Promote the Research Careers of Individuals in the Biomedical Sciences (NOT-OD-21-068) https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-068.html
Please Note: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) (PA-21-194) - Deadline June 12, 2021 https://grants.nih.gov/grants/guide/pa-files/PA-21-194.html
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) (PA-21-195) – Deadline June 12, 2021 https://grants.nih.gov/grants/guide/pa-files/PA-21-195.html
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) (PAR-21-061) - Deadline June 15, 2021 and November 17, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-061.html
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) (PAR-21-111) – Deadline June 12, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-111.html
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) (PAR-21-128) – Deadline June 12, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-128.html
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) (PAR-21-167) - Deadline June 16, 2021 and October 16, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-167.html
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) (PAR-21-169) – Deadline May 26, 2021 and May 26, 2022 https://grants.nih.gov/grants/guide/pa-files/PAR-21-169.html
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required) (PAR-21-170) – Deadline February 12, 2021 and June 12, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-170.html
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Required) (PAR-21-171) – Deadline February 12, 2021 and June 12, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-171.html
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Not Allowed) (PAR-21-172) – Deadline February 12, 2021 and June 12, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-172.html
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) (PAR-21-173) – Deadline September 28, 2021 and September 28, 2022 https://grants.nih.gov/grants/guide/pa-files/PAR-21-173.html
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional) (PAR-21-175) – Deadline June 5, 2021 and October 5, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-175.html
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional) (PAR-21-176) – Deadline June 16, 2021 and October 16, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-176.html
Research on Bat Immunology (R21 Clinical Trial Not Allowed) (PAR-21-184) – Deadline July 15, 2021 and March 15, 2022 https://grants.nih.gov/grants/guide/pa-files/PAR-21-184.html
Medical Scientist Training Program (T32) (PAR-21-189) - Deadline May 25, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-189.html
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) (PAR-21-318) – Deadline June 12, 2021 https://grants.nih.gov/grants/guide/pa-files/PAR-21-318.html
High-Priority Behavioral and Social Research Networks in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R24 Clinical Trial Optional) (RFA-AG-22-012) - Deadline June 23, 2021 https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-012.html
High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional) (RFA-AG-22-013) - Deadline June 23, 2021 https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-013.html
Early-Stage Development of Data Science Technologies for Infectious and Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) (RFA-AI-21-020) – Deadline July 2, 2021 and February 17, 2022 https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-020.html
Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed) (RFA-AI-21-021) – Deadline July 2, 2021 and February 17, 2022 https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-021.html
Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-Mediated Diseases (R21 Clinical Trial Not Allowed) (RFA-AI-21-035) – Deadline July 2, 2021 and February 17, 2022 https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-035.html
Core Centers for Clinical Research (CCCR) (P30)- Clinical Trial Not Allowed (RFA-AR-22-002) Deadline September 13, 2021 https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-22-002.html
Program to Advance the Career Development of Scientists from Diverse Backgrounds Conducting Nutrition, Obesity, Diabetes, and Related Research (U24 Clinical Trial Optional) (RFA-DK-20-034) Deadline June 17, 2021 https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-034.html
The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional) (RFA-DK-21-004) – Deadline June 22, 2021 and March 9, 2022 https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-004.html
SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership (PPP) under PASI (Pediatric Anesthesia Safety Initiative) (U01) Clinical Trials Not Allowed (RFA-FD-21-025) - Deadline May 24, 2021 https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-21-025.html
Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) (U01) Clinical Trials Not Allowed (RFA-FD-21-026) – Deadline May 24, 2021 https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-21-026.html
Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed) (RFA-OD-21-005) - Deadline June 4, 2021 https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-21-005.html
OTHER FEDERAL DEADLINES
Department of Defense (DOD) - Autism Research Program (ARP) – Clinical Trial Award – Preapplication due May 3, 2021 https://cdmrp.army.mil/funding/arp
DOD – ARP – Idea Development Award – Preapplication due May 3, 2021 https://cdmrp.army.mil/funding/arp
DOD – ARP – Clinical Translational Research Award – Preapplication due May 3, 2021 https://cdmrp.army.mil/funding/arp
DOD – ARP – Career Development Award – Preapplication due May 3, 2021 https://cdmrp.army.mil/funding/arp
DOD - Tick-Borne Disease Research Program (TBDRP) – Career Development Award – Preapplication due May 26, 2021 http://cdmrp.army.mil/funding/tbdrp
DOD - TBDRP – Career Development Award – Preapplication due May 26, 2021 http://cdmrp.army.mil/funding/tbdrp
Chan Zuckerberg Initiative – Rare As One Network (Cycle 2) – Deadline June 2, 2021 https://chanzuckerberg.com/rfa/rare-as-one/?_hsmi=116671163&_hsenc=p2ANqtz-_G7cUWM9Upe8I_ZSjyEOCgy-PUbX9oQW2rEKz3-n9PdOtw2JveWW3_DGpTRckWoIbMCKABXvrbHQ1RxdHXqweWnOu4mg
Southwest National Primate Research Center – Pilot Research Program 2021 Competition Deadline for Required Letter of Intent is April 15, 2021 https://snprc.org/pilot-research-grants/